Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-085191
Filing Date
2024-10-04
Accepted
2024-10-04 06:20:35
Documents
5
Period of Report
2024-10-04

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0216775-6k_immuron.htm 6-K 13582
2 NMRC REPORTS RESULTS FOR CAMPYLOBACTER CLINICAL STUDY ea021677501ex99-1_immuron.htm EX-99.1 20223
3 GRAPHIC ex99-1_001.jpg GRAPHIC 17461
4 GRAPHIC ex99-1_002.jpg GRAPHIC 58440
5 GRAPHIC ex99-1_003.jpg GRAPHIC 24609
  Complete submission text file 0001213900-24-085191.txt   173707
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 241353451
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)